Author

Lisa A. Ford

Observed names: Lisa A Ford, Lisa Ford

Observed institution: Metabolon (United States)

ORCID: 0000-0002-6207-8108

Observed ORCID: 0000-0002-6207-8108

OpenAlex ID: A5062945252

Precision of a Clinical Metabolomics Profiling Platform for Use in the Identification of Inborn Errors of Metabolism

2020 · Lisa Ford, Adam D Kennedy, et al. · The Journal of Applied Laboratory Medicine · 193

Metabolomic profiling to improve glomerular filtration rate estimation: a proof-of-concept study

2018 · Josef Coresh, Lesley A Inker, et al. · Nephrology Dialysis Transplantation · 53

Global biochemical analysis of plasma, serum and whole blood collected using various anticoagulant additives

2021 · Adam D. Kennedy, Lisa Ford, et al. · PLoS ONE · 40

Structure elucidation of metabolite x17299 by interpretation of mass spectrometric data

2017 · Qibo Zhang, Lisa A. Ford, et al. · Metabolomics · 30

Validation of a Metabolite Panel for a More Accurate Estimation of Glomerular Filtration Rate Using Quantitative LC-MS/MS

2019 · Tiffany A Freed, Josef Coresh, et al. · Clinical Chemistry · 25

Assessment of the effects of repeated freeze thawing and extended bench top processing of plasma samples using untargeted metabolomics

2021 · Kelli Goodman, Matthew Mitchell, et al. · Metabolomics · 21

Clinical metabolomics for inborn errors of metabolism

2022 · Lisa Ford, Matthew Mitchell, et al. · Advances in clinical chemistry · 18

LC–MS/MS method for quantitation of seven biomarkers in human plasma for the assessment of insulin resistance and impaired glucose tolerance

2016 · Qibo Zhang, Lisa A. Ford, et al. · Journal of Chromatography B · 18

Metabolomics and its Application to the Development of Clinical Laboratory Tests for Prostate Cancer.

2015 · Jonathan E McDunn, Steven M Stirdivant, et al. · PubMed · 11

Identification of an Endogenous Organosulfur Metabolite by Interpretation of Mass Spectrometric Data

2018 · Qibo Zhang, Lisa A. Ford, et al. · Organic Letters · 10

Confirmatory Clinical Validation of a Serum-Based Biomarker Signature for Detection of Early-Stage Pancreatic Ductal Adenocarcinoma

2025 · Patricio M. Polanco, Tamas Gonda, et al. · Current Oncology · 5

The PancreaSure Multianalyte Blood Test Performs Well at Distinguishing Early-Stage Pancreatic Ductal Adenocarcinoma from High-Risk Controls: A Retrospective Secondary Analysis

2026 · Tamas Gonda, Salvatore Paiella, et al. · Journal of Clinical Medicine

Biomarker Panel Designed to Detect Early-Stage Pancreatic Ductal Adenocarcinoma Also Reliably Detects Advanced Disease

2026 · Erkut Borazanci, Jan Persson, et al. · JCO oncology advances.

Biomarker Profiles of Echinacea Species Using Pressure Cycling Technology and MALDI-TOF Mass Spectrometry

2006 · R. HARRIS, Lisa A. Ford, et al.

Works count: 14

Citation count: 424

H-index: 10

I10-index: 10